Caspase-1 Cleaves Bid to Release Mitochondrial SMAC and Drive Secondary Necrosis in the Absence of GSDMD
Overview
Biology
Cell Biology
Molecular Biology
Authors
Affiliations
Caspase-1 drives a lytic inflammatory cell death named pyroptosis by cleaving the pore-forming cell death executor gasdermin-D (GSDMD). deficiency, however, only delays cell lysis, indicating that caspase-1 controls alternative cell death pathways. Here, we show that in the absence of GSDMD, caspase-1 activates apoptotic initiator and executioner caspases and triggers a rapid progression into secondary necrosis. GSDMD-independent cell death required direct caspase-1-driven truncation of Bid and generation of caspase-3 p19/p12 by either caspase-8 or caspase-9. tBid-induced mitochondrial outer membrane permeabilization was also required to drive SMAC release and relieve inhibitor of apoptosis protein inhibition of caspase-3, thereby allowing caspase-3 auto-processing to the fully active p17/p12 form. Our data reveal that cell lysis in inflammasome-activated -deficient cells is caused by a synergistic effect of rapid caspase-1-driven activation of initiator caspases-8/-9 and Bid cleavage, resulting in an unusually fast activation of caspase-3 and immediate transition into secondary necrosis. This pathway might be advantageous for the host in counteracting pathogen-induced inhibition of GSDMD but also has implications for the use of GSDMD inhibitors in immune therapies for caspase-1-dependent inflammatory disease.
PANoptosis in autoimmune diseases interplay between apoptosis, necrosis, and pyroptosis.
Liu K, Wang M, Li D, Duc Duong N, Liu Y, Ma J Front Immunol. 2024; 15:1502855.
PMID: 39544942 PMC: 11560468. DOI: 10.3389/fimmu.2024.1502855.
Inflammasome-mediated pyroptosis in defense against pathogenic bacteria.
Oh C, Spears T, Aachoui Y Immunol Rev. 2024; 329(1):e13408.
PMID: 39404258 PMC: 11741929. DOI: 10.1111/imr.13408.
Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation.
Al Mamun A, Geng P, Wang S, Shao C J Inflamm Res. 2024; 17:7037-7056.
PMID: 39377044 PMC: 11457779. DOI: 10.2147/JIR.S486878.
Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives.
Hu D, Sheeja Prabhakaran H, Zhang Y, Luo G, He W, Liou Y Crit Care. 2024; 28(1):292.
PMID: 39227925 PMC: 11373266. DOI: 10.1186/s13054-024-05069-w.
Multiple sclerosis: the NLRP3 inflammasome, gasdermin D, and therapeutics.
Brint A, Greene S, Fennig-Victor A, Wang S Ann Transl Med. 2024; 12(4):62.
PMID: 39118955 PMC: 11304424. DOI: 10.21037/atm-23-1960.